Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

News Features

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

December 14, 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices

News Daily News

CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices

Michael O'Riordan

October 30, 2020

In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out

News Daily News

In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out

September 18, 2020

Open Letter Calls on CV Societies to Discourage CMR After Mild COVID-19

News Daily News

Open Letter Calls on CV Societies to Discourage CMR After Mild COVID-19

September 15, 2020

‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study

News Daily News

‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study

Michael O'Riordan

August 26, 2020

Super-Responders in COAPT: Improving MR and QoL Is Key

News Daily News

Super-Responders in COAPT: Improving MR and QoL Is Key

August 24, 2020

TCTMD’s Top 10 Most Popular Stories for June 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2020

July 02, 2020

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

News Daily News

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Yael L. Maxwell

May 21, 2020

Latest Kawasaki Series Offers Clues to COVID-19 in Kids as Debate Persists

News Daily News

Latest Kawasaki Series Offers Clues to COVID-19 in Kids as Debate Persists

May 14, 2020

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

Trials of New Cancer Drugs Failing to Address Potential CV Risks

News Daily News

Trials of New Cancer Drugs Failing to Address Potential CV Risks

February 10, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.